Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Expands By 453.7%

Clearmind Medicine Inc. (NASDAQ:CMND) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 620,700 shares, an increase of 453.7% from the December 15th total of 112,100 shares. Approximately 21.0% of the shares of the company are short sold. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is currently 0.5 days.

Clearmind Medicine Price Performance

CMND remained flat at $1.53 during trading hours on Monday. The company had a trading volume of 203,566 shares, compared to its average volume of 415,500. The business’s fifty day moving average is $1.40 and its 200-day moving average is $1.41. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.71 and a quick ratio of 1.71. Clearmind Medicine has a 12-month low of $0.92 and a 12-month high of $2.30.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.